| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2019/04/12 | 03 : 00 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 2018/05/23 | 02 : 18 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 2018/04/10 | 05 : 54 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 2018/03/23 | 03 : 12 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 2018/03/22 | 19 : 01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 2018/03/22 | 19 : 01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 2018/03/22 | 19 : 01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 2018/03/22 | 19 : 01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 2018/03/20 | 04 : 17 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 2018/03/14 | 07 : 16 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 2018/03/14 | 07 : 12 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 2018/03/14 | 07 : 12 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 2018/03/14 | 07 : 12 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 2018/03/14 | 07 : 11 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 2018/03/14 | 07 : 11 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 2018/03/14 | 07 : 10 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 2018/03/14 | 07 : 10 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 2018/03/14 | 07 : 09 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 2018/03/14 | 07 : 09 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 2018/03/14 | 07 : 08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 2018/03/14 | 07 : 08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 2018/03/14 | 07 : 08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 2018/03/14 | 07 : 08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 2018/03/14 | 07 : 08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 2018/03/14 | 07 : 08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 2018/03/14 | 07 : 08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 2018/03/14 | 07 : 07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 2018/03/14 | 07 : 04 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 2018/03/14 | 07 : 03 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 2018/03/14 | 07 : 02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |